New Division Directors for Core Services and Logistics

Following the promotion of Dr. Joanna Barbara, PhD, to Vice President of Scientific Operations, Dr. Etsuko Usuki, PhD, has been promoted to the position of Division Director for XenoTech’s Core Services. Etsuko received her PhD in Analytical Chemistry from Virginia Polytechnic Institute and State University, and BS in Pharmaceutical Sciences from Kobegakuin University in Japan. After working as an Analytical Chemist at Takeda and Postdoctoral Research Associate at the Harvey W. Peters Center for the Study of Parkinson’s Disease (VA Tech), she joined XenoTech as a Senior Scientist for the Drug Metabolism Department in 1998. Dr. Usuki is responsible for directing the implementation of XenoTech’s quality vision throughout the Program Execution, Program Oversight and Lab Operations teams, with a focus on scientific quality in the lab, interpretation of data and study oversight.

Andrea Wolff has been appointed to the newly created position of Division Director for XenoTech’s Services Logistics. Andrea received her Bachelors of Science with a double major in Chemistry and Biology at Baker University and joined the XenoTech team in 1999. She has more than 15 years of experience with GLP and non-GLP in vitro metabolism and transporter studies at XenoTech. Her experience started as an analyst and then Study Director focusing on in vitro drug metabolism studies. After over 10 years focusing on in vitro metabolism, her focus shifted to in vitro drug transporter studies, serving as a Study Director and then Manager for 5 years. She then expanded her focus, managing drug interaction studies across multiple disciplines (in vitro drug metabolism, drug transporters, enzyme induction and enzyme inhibition) and providing guidance to clients on the regulatory requirements for performing in vitro drug interaction studies. Andrea now manages several core service support teams that cover protocol writing, report writing, data processing and project management. She is responsible for the quality and timelines associated with all contract study deliverables executed at XenoTech.

Learn more about XenoTech’s management team

Learn more about: